Profile | GDS4284 / 232205_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1136.64 | 76 |
GSM687648 | Patient 402 control | 789.598 | 70 |
GSM687653 | Patient 403 control | 1075.79 | 75 |
GSM687658 | Patient 404 control | 1317.15 | 78 |
GSM687663 | Patient 411 control | 1452.31 | 79 |
GSM687668 | Patient 422 control | 944.402 | 73 |
GSM687673 | Patient 424 control | 1355.48 | 78 |
GSM687678 | Patient 425 control | 1105.09 | 75 |
GSM687683 | Patient 427 control | 1069.01 | 74 |
GSM687688 | Patient 428 control | 1285.98 | 78 |
GSM687695 | Patient 441 control | 562.714 | 64 |
GSM687699 | Patient 443 control | 677.549 | 68 |
GSM687704 | Patient 444 control | 1549.76 | 80 |
GSM687707 | Patient 448 control | 1297.58 | 78 |
GSM687712 | Patient 449 control | 924.652 | 73 |
GSM687719 | Patient 450 control | 690.997 | 68 |
GSM687724 | Patient 451 control | 1506.54 | 80 |
GSM687728 | Patient 452 control | 1261.4 | 78 |
GSM687646 | Patient 401 treated 24h | 1317.07 | 78 |
GSM687649 | Patient 402 treated 24h | 828.56 | 71 |
GSM687665 | Patient 411 treated 24h | 1518.16 | 80 |
GSM687651 | Patient 402 treated 4 weeks | 843.556 | 71 |
GSM687667 | Patient 411 treated 4 weeks | 1502.19 | 80 |
GSM687670 | Patient 422 treated 24h | 1110.4 | 75 |
GSM687671 | Patient 422 treated 4 weeks | 938.781 | 73 |
GSM687654 | Patient 403 treated 24h | 1239.79 | 77 |
GSM687675 | Patient 424 treated 24h | 1079.25 | 75 |
GSM687685 | Patient 427 treated 24h | 1375.09 | 79 |
GSM687656 | Patient 403 treated 4 weeks | 1078.96 | 75 |
GSM687677 | Patient 424 treated 4 weeks | 1552.43 | 80 |
GSM687687 | Patient 427 treated 4 weeks | 1246.69 | 77 |
GSM687692 | Patient 428 treated 4h | 1134.05 | 76 |
GSM687716 | Patient 449 treated 4h | 909.517 | 73 |
GSM687722 | Patient 450 treated 4h | 879.772 | 72 |
GSM687680 | Patient 425 treated 24h | 1221.34 | 77 |
GSM687690 | Patient 428 treated 24h | 1216.38 | 77 |
GSM687700 | Patient 443 treated 24h | 914.907 | 72 |
GSM687705 | Patient 444 treated 24h | 1222.26 | 77 |
GSM687714 | Patient 449 treated 24h | 856.3 | 72 |
GSM687721 | Patient 450 treated 24h | 742.616 | 69 |
GSM687682 | Patient 425 treated 4 weeks | 1446.41 | 79 |
GSM687694 | Patient 428 treated 4 weeks | 1152.21 | 76 |
GSM687702 | Patient 443 treated 4 weeks | 954.418 | 73 |
GSM687718 | Patient 449 treated 4 weeks | 983.279 | 74 |
GSM687723 | Patient 450 treated 4 weeks | 1101.89 | 75 |
GSM687661 | Patient 404 treated 4h | 1184.33 | 76 |
GSM687710 | Patient 448 treated 4h | 1111.58 | 76 |
GSM687726 | Patient 451 treated 4h | 1939.79 | 84 |
GSM687730 | Patient 452 treated 4h | 1933.05 | 85 |
GSM687660 | Patient 404 treated 24h | 740.668 | 71 |
GSM687697 | Patient 441 treated 24h | 791.487 | 71 |
GSM687709 | Patient 448 treated 24h | 1030.43 | 75 |
GSM687725 | Patient 451 treated 24h | 1617.63 | 81 |
GSM687729 | Patient 452 treated 24h | 1069 | 77 |
GSM687727 | Patient 451 treated 4 weeks | 2471.63 | 87 |
GSM687731 | Patient 452 treated 4 weeks | 1370.29 | 79 |